BIOSHELL IGG 1000A C4 2.7UM 10CM X 4.6MM

Code: 63328-u D2-231

Application

UHPLC Analysis of Trastuzumab on BIOshell IgG 1000 Å C4, 2.7 µmUHPLC Analysis of IgG2 on BIOshell IgG 1000 Å C4, C18, and...


read more

Your Price
£879.00 EACH
£1,054.80 inc. VAT

Application

UHPLC Analysis of Trastuzumab on BIOshell IgG 1000 Å C4, 2.7 µmUHPLC Analysis of IgG2 on BIOshell IgG 1000 Å C4, C18, and Diphenyl, 2.7 µm

General description

BIOshell IgG 1000Å C4 is a high-speed, high-performance liquid chromatography column based on a new wide-pore (1000Å) Fused-Core® particle design. The Fused-Core particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.5-micron thin porous shell and the small overall particle size of 2.7-microns. The densely bonded, extensively endcapped dimethylbutyl stationary phase of BIOshell IgG 1000Å C4 provides a stable, reversed-phase packing that can be used for separating high molecular weight compounds such as proteins.

Legal Information

BIOshell is a trademark of Sigma-Aldrich Co. LLC

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

agencysuitable for USP L26
descriptionSolid core (1.7 µm), Shell thickness (0.5 µm)
extent of labeling0.6% carbon loading
featureendcapped
L × I.D.10 cm × 4.6 mm
manufacturer/tradenameBIOshell
materialstainless steel hardware
matrix active groupC4 (butyl) phase
matrixsuperficially porous particle, spherical silica particle platform
operating pH range2-9
packaging1 ea of
parameter600 bar pressure, 90 °C max. temp.
particle size2.7 µm
pore size1000 Å
product lineBIOshell
Quality Level500
separation techniquereversed phase
specific analyte(s)IgG
surface area22 m2/g
technique(s)UHPLC-MS: suitable, HPLC: suitable, LC/MS: suitable, UHPLC: suitable
This product has met the following criteria: